Anne I. Sperling to Idiopathic Pulmonary Fibrosis
This is a "connection" page, showing publications Anne I. Sperling has written about Idiopathic Pulmonary Fibrosis.
Connection Strength
1.901
-
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 10; 211(10):1823-1834.
Score: 0.733
-
ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol. 2018 01; 11(1):61-70.
Score: 0.410
-
The Role of Matrix Metalloproteinase 12 in Distinguishing Idiopathic Pulmonary Fibrosis From Fibrotic Hypersensitivity Pneumonitis. Chest. 2026 Jul; 170(1):157-168.
Score: 0.189
-
Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2023 02; 10(1).
Score: 0.152
-
Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFß signaling through TGFBR1 stabilization. Nat Commun. 2020 08 26; 11(1):4254.
Score: 0.129
-
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 10; 158(4):1526-1534.
Score: 0.126
-
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 06 15; 199(12):1517-1536.
Score: 0.118
-
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis. Am J Respir Crit Care Med. 2024 11 15; 210(10):1252-1266.
Score: 0.043